Clinical Study Results
Research Sponsor: AstraZeneca
Drugs Studied: AZD9496 and fulvestrant
Study Title: A study to learn how AZD9496 works in participants with breast
cancer compared with fulvestrant
Thank you!
Thank you for taking part in the clinical study for the study drug AZD9496. You
and all of the participants helped researchers learn more about AZD9496 to help
people with breast cancer.
AstraZeneca sponsored this study and thinks it is important to share the results of
the study with you and the public. An independent non-profit organisation called
CISCRP helped prepare this summary of the study results for you. We hope it
helps you understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in October 2017 and ended in February 2019.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
The study included 49 participants in Germany and the United Kingdom.
1